TREN PENGGUNAAN ANTIBIOTIKA LINI 3 DI RS X BEKASI PERIODE TRIWULAN I TAHUN 2020 DIBANDINGKAN DENGAN TRIWULAN IV TAHUN 2019

  • Kurniatul Hasanah Poltekkes Hermina
Keywords: PPRA, Antibiotics, Line 3 Antibiotics, Quantitative Evaluation of Antibiotic Use

Abstract

Antibiotics are the most widely used drugs in the treatment of infections caused by bacteria. Resistance of microorganisms to antibiotics, pharmacokinetic and pharmacodynamic factors, drug interactions and side effects and cost factors are needed to be considered in their use. The use of antibiotics needs to be evaluated quantitatively and qualitatively. The study was conducted to determine and evaluate the use of line 3 antibiotics quantitatively in the X Bekasi Hospital in the first quarter of 2020 compared to the fourth quarter of 2019. It was descriptive study with retrospective data collection using total sampling technique. There are 13 types of antibiotics that are included in the line 3 antibiotics used at X Bekasi Hospital. The percentage of use of line 3 antibiotics in the first quarter of 2020 compared to the fourth quarter of 2019 increased by 26.9% for the use of amikacin 250 mg injection but decreased by 100% for the use of amikacin 500 mg injection, increased by 17.8% for the use of meropenem 0.5 g injection but decreased by 16.1% for the use of meropenem 1 g injection, decreased by 100% for the use of imipenem-cilastatin injection, linezolid 600 mg injection and vancomycin 500 mg injection, decreased by 212.5%, 53.6%, 41.2% and 69.2% each for the use of doripenem 500 mg injection, decreased, ceftazidime 1 g injection, cefepime 1 g injection and piperacillin tazobactam injection, and increased 75% for the use of tigecycline 50 mg injection. The use of line 3 antibiotics in X Bekasi Hospital was very large and varied in the fourth quarter of 2019 compared to the first quarter of 2020. A very significant amount was seen in the use of imipenem-cilastatin injection, linezolid 600 mg injection and vancomycin 500 mg injection.

Downloads

Download data is not yet available.

References

Anggraini, W., Sugihantoro, H., & Ludfiyah, F. (2021). Evaluasi Kuantitatif Penggunaan Antibiotik di Ruang Perawatan Airlangga dan Peta Kuman RSUD Kanjuruhan Malang Periode Juli-Desember 2018. Indonesian Journal of Clinical Pharmacy, 10(2), 90. https://doi.org/10.15416/ijcp.2021.10.2.90

Badan POM RI. (n.d.). 5.1. Antibakteri. Online at http://pionas.pom.go.id/ioni/bab-5-infeksi/51-antibakteri, accessed 20 December 2021

MacGowan, A. P., Darley, E. S. R., Jacobson, S. K., Smith, D., & Urch, J. (2020). Antibiotic Guidelines 2020. July, 47.

Menteri Kesehatan RI. (2011). Permenkes No. 2406 Tahun 2011 tentang Pedoman Umum Penggunaan Antibiotik.

Menteri Kesehatan RI. (2015). Permenkes No. 8 Tahun 2015 tentang PPRA.

Tambunan, T. (2004). Keputusan Klinik dalam Penggunaan Antibiotik. 6(1), 52–56.

WHO. (2011). Step-by-step approach for development and implementation of hospital antibiotic policy and standard treatment guidelines.
Published
2022-01-28
How to Cite
Hasanah, K. (2022). TREN PENGGUNAAN ANTIBIOTIKA LINI 3 DI RS X BEKASI PERIODE TRIWULAN I TAHUN 2020 DIBANDINGKAN DENGAN TRIWULAN IV TAHUN 2019. Jurnal Riset Kefarmasian Indonesia, 4(1), 101-110. https://doi.org/10.33759/jrki.v4i1.227
Views Statistic
  • Abstract 117
  • PDF 85